ストックスクリーナーアプリを入手
37.32
2.79%
-1.07
プレマーケット:
36.25
-1.07
-2.87%
前日終値:
$38.39
開ける：
$38.59
24時間の取引高:
236.50K
Relative Volume:
1.18
時価総額：
$618.31M
収益：
$102.48M
当期純損益:
$-191.09M
株価収益率:
-2.588
EPS:
-14.4203
ネットキャッシュフロー:
$-178.93M
1週間 パフォーマンス:
+7.58%
1か月 パフォーマンス:
+56.94%
6か月 パフォーマンス:
+279.23%
1年 パフォーマンス:
+255.43%
1日の値動き範囲:
$36.31
$39.74
1週間の範囲:
$31.76
$39.74
52週間の値動き範囲:
$6.736
$39.74
Sutro Biopharma Inc Stock (STRO) Company Profile
名前
Sutro Biopharma Inc
セクター
電話
650-392-8412
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
37.32 | 618.31M | 102.48M | -191.09M | -178.93M | -14.42 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-07 | 開始されました | Leerink Partners | Outperform |
| 2026-03-24 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2026-03-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-20 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-06-16 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-03-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-05-08 | 開始されました | BofA Securities | Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-06 | 開始されました | Oppenheimer | Outperform |
| 2023-03-21 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 再開されました | Wells Fargo | Overweight |
| 2021-06-18 | 開始されました | H.C. Wainwright | Buy |
| 2020-12-03 | 開始されました | Stifel | Buy |
| 2020-09-02 | 開始されました | Jefferies | Buy |
| 2020-07-16 | 開始されました | Wells Fargo | Overweight |
| 2020-01-13 | 開始されました | SunTrust | Buy |
| 2019-10-07 | 開始されました | BTIG Research | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2019-04-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-10-22 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-10-22 | 開始されました | Piper Jaffray | Overweight |
| 2018-10-22 | 開始されました | Wedbush | Outperform |
すべてを表示
Sutro Biopharma Inc (STRO) 最新ニュース
Sutro Biopharma (NASDAQ:STRO) Upgraded at Lifesci Capital - MarketBeat
Citizens Raises Sutro Biopharma Price Target to 41 Dollars - HarianBasis.co
Point72 group (NASDAQ: STRO) reports 5.7% stake — 946,829 shares - Stock Titan
Sutro Biopharma (NASDAQ:STRO) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program - Insider Monkey
Mizuho initiates coverage of Sutro Biopharma (STRO) with outperform recommendation - MSN
Sutro Biopharma: Recycling Past Data Ahead Of The Readout, Sell - Seeking Alpha
MSN Money - MSN
This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday - Benzinga
Mizuho Securities Initiates Sutro Biopharma(STRO.US) With Buy Rating, Announces Target Price $50 - Moomoo
Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Grows By 17.0% - MarketBeat
Mizuho Initiates Sutro Biopharma at Outperform With $50 Price Target - marketscreener.com
STRO Initiated Coverage by Mizuho -- Rating Set at Outperform - GuruFocus
Mizuho initiates Sutro Biopharma stock coverage with outperform rating By Investing.com - Investing.com India
Mizuho initiates Sutro Biopharma stock coverage with outperform rating - Investing.com
Sutro Biopharma (NASDAQ:STRO) Hits New 1-Year HighWhat's Next? - MarketBeat
Sutro Biopharma Strengthens Financial Position and Advances ADC Pipeline - HarianBasis.co
Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now - Insider Monkey
5 Tiny Stocks That Are On Fire Right Now - Insider Monkey
Sutro Biopharma (NASDAQ:STRO) Shares Up 5.6%What's Next? - MarketBeat
Sutro Biopharma (STRO) price target decreased by 21.62% to 29.58 - MSN
Sutro Biopharma prices $110M common stock offering - MSN
Sutro Biopharma, Inc. (STRO) Presents at AACR Annual Meeting 2026Slideshow (NASDAQ:STRO) 2026-04-24 - Seeking Alpha
Sutro Biopharma (NASDAQ:STRO) Shares Down 6.1%Time to Sell? - MarketBeat
STRO Maintains by Citizens -- Price Target Raised to $41.00 - GuruFocus
Citizens Jmp Boosts Sutro Biopharma (NASDAQ:STRO) Price Target to $41.00 - MarketBeat
Citizens raises Sutro Biopharma stock price target on platform value By Investing.com - Investing.com Canada
Citizens JMP Maintains Sutro Biopharma(STRO.US) With Buy Rating, Raises Target Price to $41 - Moomoo
STRO (Sutro Biopharma Inc.) posts 65.2 percent year over year revenue growth but misses EPS estimates, sending shares slightly lower.Restructuring - Cổng thông tin điện tử tỉnh Lào Cai
STRO Sutro Biopharma Q4 2025 EPS misses estimates, shares rise 3.01 percent on strong 65.2 percent revenue growth.High Interest Stocks - Xã Thanh Hà
Sutro Biopharma (NASDAQ: STRO) outlines 2026 vote on board, pay and auditor - Stock Titan
STRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Millennium entities report 210,378 shares in Sutro Biopharma (STRO) — joint filing - Stock Titan
Perceptive Advisors, Joseph Edelman report 5.4% stake in Sutro Biopharma (NASDAQ: STRO) - Stock Titan
Sutro Biopharma (NASDAQ:STRO) Reaches New 1-Year HighStill a Buy? - MarketBeat
Sutro Biopharma, Inc. $STRO Shares Sold by JPMorgan Chase & Co. - MarketBeat
Sutro Biopharma presents promising preclinical data on ADC pipeline at AACR Annual Meeting - Traders Union
Sutro Biopharma (STRO) Reveals Strong Preclinical Results for Ne - GuruFocus
Sutro Biopharma Presents Promising Preclinical Data For Pipeline ADC Programs At AACR 2026 - RTTNews
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 - The Manila Times
Sutro Biopharma Reports Promising Preclinical Data for Next-Generation ADCs STRO-004, STRO-006, and STRO-227 at AACR Annual Meeting 2026 - Quiver Quantitative
Sutro's cancer drug candidate outperformed benchmark ADCs in lab models - Stock Titan
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Up 20.1% in March - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Trading Up 10.4% After Analyst Upgrade - MarketBeat
STRO Maintained by Citizens -- Price Target Raised to $35.00 - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
Citizens raises Sutro Biopharma stock price target on pipeline value By Investing.com - Investing.com Canada
Citizens JMP Maintains Sutro Biopharma(STRO.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Sutro Biopharma Hits New 52-Week High - National Today
Sutro Biopharma (NASDAQ:STRO) Reaches New 52-Week HighHere's What Happened - MarketBeat
Momentum Shift: Is Sutro Biopharma Inc benefiting from interest rate changes2026 Drop Watch & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Sutro Biopharma Inc (STRO) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):